GlassScriptPhysician profile
Anas Raowas
NPI 1376816249
$19,130.54
in general payments reported to CMS, 2019-2025
82 companies · $5,865 in 2025
The $5,865 reported for 2025 was more than what 84% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,165 · 2020: $1,003 · 2021: $1,120 · 2022: $2,215 · 2023: $2,703 · 2024: $4,059 · 2025: $5,865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,511.97 |
| Education | $114.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,456.29 | 2019-2025 | Imfinzi, Calquence, Enhertu |
| Pfizer INC. | $1,429.49 | 2019-2025 | |
| Celgene Corporation | $1,043.21 | 2019-2025 | Pomalyst, Reblozyl, Opdualag |
| Janssen Biotech, INC. | $1,039.53 | 2020-2025 | Tecvayli, Darzalex, Rybrevant |
| E.R. Squibb & Sons, L.L.C. | $1,024.99 | 2019-2025 | Opdivo, Reblozyl, Opdualag |
| Glaxosmithkline, LLC. | $730.70 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Merck Sharp & Dohme LLC | $707.05 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $643.33 | 2024-2025 | |
| Karyopharm Therapeutics INC. | $541.37 | 2021-2025 | Xpovio |
| Eisai INC. | $526.59 | 2019-2025 | |
| Genzyme Corporation | $491.83 | 2019-2025 | |
| Array Biopharma INC | $488.90 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Abbvie INC. | $465.10 | 2021-2025 | |
| Sobi, INC | $461.97 | 2022-2025 | Doptelet |
| Bayer Healthcare Pharmaceuticals INC. | $449.09 | 2023-2025 |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $388.90 | 2019-2025 | Trodelvy |
| Amgen INC. | $364.09 | 2021-2025 | Lumakras, Kyprolis, Kyprolis |
| Genentech USA, INC. | $321.35 | 2019-2025 | Polivy, Lunsumio, Tecentriq |
| Incyte Corporation | $314.05 | 2019-2025 | Jakafi |
| Rigel Pharmaceuticals, INC. | $285.97 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Seagen INC. | $284.04 | 2020-2023 | Tukysa, Adcetris, Padcev |
| Pharmacyclics LLC, An Abbvie Company | $282.30 | 2019-2023 | Imbruvica, Epkinly |
| Takeda Pharmaceuticals U.S.A., INC. | $271.26 | 2022-2025 | Iclusig, Fruzaqla, Ninlaro |
| Regeneron Healthcare Solutions, INC. | $252.33 | 2020-2025 | Libtayo |
| Aveo Pharmaceuticals, INC. | $222.37 | 2021-2025 | Fotivda |
| Daiichi Sankyo INC. | $222.18 | 2022-2025 | Enhertu, Datroway, Injectafer |
| Csl Behring | $220.05 | 2019-2024 | Idelvion, Afstyla |
| Alexion Pharmaceuticals, INC. | $217.19 | 2023-2025 | Ultomiris |
| Astellas Pharma US INC | $206.53 | 2022-2025 | Padcev, Xtandi, Vyloy |
| Puma Biotechnology, INC. | $205.76 | 2022-2025 | Nerlynx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $203.47 | 2020-2025 | Gilotrif |
| Stemline Therapeutics INC. | $200.69 | 2020-2025 | Orserdu |
| Lilly USA, LLC | $194.75 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Kite Pharma, INC. | $182.23 | 2020-2025 | Yescarta |
| Coherus Oncology, INC. | $161.12 | 2024-2025 | Loqtorzi |
| Adc Therapeutics America, INC. | $154.04 | 2024-2025 | |
| Caris Mpi, INC. | $148.66 | 2025 | Mi Cancer Seek |
| Beigene USA, INC. | $132.54 | 2022-2025 | Brukinsa, Tevimbra |
| Blueprint Medicines Corporation | $131.86 | 2020-2024 | Ayvakit |
| Beone Medicines USA, INC. | $118.76 | 2025 | Brukinsa, Tevimbra |
| Exelixis INC. | $113.35 | 2023-2025 | Cabometyx |
| Agios Pharmaceuticals, INC. | $100.13 | 2020-2025 | Pyrukynd |
| Jazz Pharmaceuticals INC. | $95.84 | 2024-2025 | |
| Emd Serono, INC. | $92.67 | 2019-2025 | |
| Tersera Therapeutics LLC | $82.19 | 2021-2022 | |
| Pharmacosmos Therapeutics INC. | $78.25 | 2022-2025 | Monoferric, Cosela |
| Pharmaessentia USA Corporation | $67.47 | 2025 | Besremi |
| Iovance Biotherapeutics, INC. | $66.18 | 2025 | Amtagvi |
| Kyowa Kirin, INC. | $65.83 | 2022-2025 | Poteligeo |
| Sumitomo Pharma America, INC. | $62.73 | 2024-2025 | Orgovyx |
| Verity Pharmaceuticals INC. | $62.18 | 2022-2025 | Trelstar |
| Ipsen Biopharmaceuticals, INC | $60.18 | 2021-2024 | Onivyde, Somatuline Depot, Tazverik |
| Taiho Oncology, INC. | $58.22 | 2022-2025 | |
| Tempus Ai, INC | $57.10 | 2024-2025 | Xt Cdx |
| Octapharma USA, INC. | $52.79 | 2021-2022 | |
| Legend Biotech USA INC. | $52.49 | 2025 | Carvykti |
| Eusa Pharma (US) LLC | $49.77 | 2021-2022 | |
| Foundation Medicine, INC. | $49.45 | 2019 | |
| Dendreon Pharmaceuticals LLC | $48.08 | 2020-2025 | Provenge |
| Teva Pharmaceuticals USA, INC. | $42.94 | 2019 | |
| Genmab U.S., INC. | $42.93 | 2024-2025 | Epkinly |
| Deciphera Pharmaceuticals INC. | $37.89 | 2025 | Tgct, Qinlock |
| Mylan Institutional INC. | $37.88 | 2019-2020 | |
| Novocure INC. | $37.55 | 2025 | Optune Gio |
| Myriad Genetic Laboratories, INC. | $37.27 | 2021-2025 | Myrisk |
| Chiesi USA, INC. | $32.84 | 2021 | |
| Adaptive Biotechnologies Corporation | $32.02 | 2024 | Clonoseq |
| Acrotech Biopharma INC. | $30.24 | 2023 | Beleodaq |
| Myovant Sciences INC. | $28.60 | 2022 | |
| Ge Healthcare | $28.57 | 2025 | |
| Springworks Therapeutics, INC. | $28.28 | 2024 | Ogsiveo |
| Progenics Pharmaceuticals, INC. | $26.98 | 2024 | |
| Accord Healthcare, INC. | $24.63 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $23.24 | 2019 | |
| Telix Pharmaceuticals | $22.42 | 2023 | Illuccix |
| Fennec Pharmaceuticals, INC. | $20.29 | 2025 | Fyarro |
| Cumberland Pharmaceuticals, INC. | $20.05 | 2024 | Sancuso |
| Global Blood Therapeutics, INC. | $18.95 | 2022 | |
| Sun Pharmaceutical Industries INC. | $18.89 | 2023 | Odomzo, Yonsa |
| Amneal Pharmaceuticals LLC | $16.94 | 2023 | Avastin, Neupogen, Neulasta |
| Azurity Pharmaceuticals, INC. | $14.35 | 2025 | Danziten, Vivimusta |
| Emmaus Medical, INC. | $5.96 | 2023 | Endari |
Drugs and devices associated with these payments
Xpovio $516Lenvima $492Tecvayli $490Darzalex $391Imfinzi $353Pomalyst $349Nubeqa $338Doptelet $331Elrexfio $291Adcetris $286Reblozyl $285Tukysa $281Braftovi $280Imbruvica $256Calquence $256Kisqali $238Enhertu $230Mektovi $229Keytruda $225Ultomiris $217Rybrevant $216Padcev $213Carvykti $191Talvey $190Ojjaara $181Orserdu $179Zejula $175Sarclisa $172Libtayo $171Orgovyx $166Bosulif $165Fotivda $165Jakafi $161Opdivo $159Xtandi $158Rezlidhia $153Tavalisse $153Idelvion $152Afstyla $152Mi Cancer Seek $149Scemblix $146Loqtorzi $145Inlyta $143Trodelvy $141Jemperli $134Ibrance $133Lynparza $132Lorbrena $129Iclusig $123Zynlonta $122Epkinly $121Cabometyx $113Brukinsa $111Stivarga $111Vitrakvi $93.49Elahere $89.84Tevimbra $89.37Opdualag $85.33Nerlynx $82.81Venclexta $82.18Pluvicto $77.34Yescarta $75.58Fabhalta $70.81Fruzaqla $69.93Besremi $67.47Jaypirca $67.13Amtagvi $66.18Talzenna $66.07Synagis $65.61Pyrukynd $65.60Zepzelca $63.49Lutathera $60.42Xalkori $58.13Optune Gio $56.22Comirnaty $55.41Paxlovid $55.41Akeega $55.09Erleada $55.09Balversa $55.09Poteligeo $51.74Verzenio $51.43Mekinist $50.52Trelstar $45.30Datroway $44.85Illuccix $44.84Ayvakit $44.65Altuviiio $41.07Monoferric $40.65Polivy $39.52Inqovi $38.51Lonsurf $38.51Lumakras $37.96Qinlock $37.89Tgct $37.89Elitek $36.72Tivdak $35.46Ziihera $32.35Clonoseq $32.02Provenge $30.35Beleodaq $30.24
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anas Raowas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.